News
SPR Therapeutics Receives Red Herring Top 100 Award
Ohio company is the only recipient in the state and one of only two medical device companies in the country to be recognized as a Top 100 winner Read the…
National Institutes of Health Awards SPR Therapeutics $2.9 Million Grant To Study Treatment for Pain After Stroke
Small Business Innovation Research award helps fund final phase of clinical research for medical device that uses electrical stimulation to relieve shoulder pain in stroke patients. Read the full article (PDF)
SPR Therapeutics featured on a NPR news story: A More Direct Way to Treat Pain is Being Developed in Cleveland.
A new electric nerve stimulation device for drug free joint pain relief is nearing FDA approval Read the full article here
SPR’s Smartpatch Percutaneous PNS System Receives Australian Regulatory Approval
Smartpatch is the world’s first and only approved percutaneous PNS system for the treatment of chronic shoulder pain. Read the full article (PDF)
SPR Therapeutics, in collaboration with Case Western Reserve University, NDI Medical, and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
Grant Awarded to Commercialize a Revolutionary Modular Neurostimulation System Designed to Address Neurological Conditions and Injuries Read the full article here
SPR Therapeutics Receives CE Mark for Smartpatch PNS System
Neurodevice firm SPR Therapeutics has received the CE mark for its Smartpatch system, a peripheral nerve stimulation (PNS) therapy for the minimally-invasive treatment of pain. Read the full article here
SPR Therapeutics Raises $5 Million Series A
Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. Read the full article here
Want to stay informed?
Get the latest on patient success cases, studies, training webinars and more delivered to your inbox.
